NCT06751199View on ClinicalTrials.gov

UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

July 30, 2026

Study Completion Date

December 1, 2026

Conditions
Diabetes
Interventions
DRUG

human umbilical cord mesenchymal stem cells

Portal vein infusion human umbilical cord mesenchymal stem cells

DRUG

allogeneic islet

Portal vein infusion of allogeneic islet

Trial Locations (1)

Unknown

RECRUITING

Shanghai Changzheng Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Changzheng Hospital

OTHER